Incyte Genomics, Inc. (INCY) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $120.48 -0.49%
Financial Fact:
Selling, general and administrative: 75.78M
Today's EPS Names:
COHR, LVWD, FWDI, More
Financial Fact:
Selling, general and administrative: 75.78M
Today's EPS Names:
COHR, LVWD, FWDI, More
Join SI Premium – FREE
Incyte Genomics, Inc. (NASDAQ: INCY) reported Q3 loss of ($0.42), $0.03 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $16.54 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cisco Systems (CSCO) Tops Q4 EPS by 5c; offers guidance
- Data I/o Corp (DAIO) Misses Q3 EPS by 3c
- SDCH (SDCH) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
